Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.4K
Cancer Vaccines01:30

Cancer Vaccines

742
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
742
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyanidin-3-O-Glucoside Protects Against Cognitive Impairment in D-Galactose-Induced Aging Mice by Regulating Nrf2 and NF-κB Pathways.

Nutrients·2026
Same author

<i>Klebsiella pneumoniae</i> ghosts as a novel adjuvant drive dendritic cell maturation and antigen-specific TCM expansion for IFN-γ-mediated immune protection.

Infection and immunity·2025
Same author

AI-powered three-category <i>Helicobacter pylori</i> diagnosis via magnetic controlled capsule endoscopy: a multicenter validation of a vision-language model.

Frontiers in microbiology·2025
Same author

Protective Effects of Black Rice Anthocyanins on D-Galactose-Induced Renal Injury in Mice: The Role of Nrf2 and NF-κB Signaling and Gut Microbiota Modulation.

Nutrients·2025
Same author

K. pneumoniae ghosts serve as a novel vaccine formulation to enhance immune responses of A. baumannii subunit vaccine in mice.

Microbial pathogenesis·2024
Same author

A very rare cause of markedly elevated CA 19-9: Glucagon-like peptide-1 receptor agonists.

Diabetes & metabolism·2024

Related Experiment Video

Updated: Dec 1, 2025

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.0K

Adaptive Tracking Control for Uncertain Cancer-Tumor-Immune Systems.

Hongmei Jiao, Qikun Shen, Yan Shi

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |November 6, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces an adaptive control method for cancer-tumor-immune systems, effectively stopping tumor growth and stabilizing cell populations. The novel approach overcomes previous limitations, ensuring system stability and accurate error convergence for cancer control.

    More Related Videos

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
    07:46

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

    Published on: April 30, 2021

    5.2K
    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
    10:19

    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

    Published on: May 12, 2023

    1.5K

    Related Experiment Videos

    Last Updated: Dec 1, 2025

    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
    08:17

    Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

    Published on: June 7, 2015

    16.0K
    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
    07:46

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

    Published on: April 30, 2021

    5.2K
    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
    10:19

    Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

    Published on: May 12, 2023

    1.5K

    Area of Science:

    • Mathematical Biology
    • Control Theory
    • Immunology

    Background:

    • Cancer-tumor-immune system dynamics are complex and challenging to model and control.
    • Existing control methods face limitations such as singularity issues and design inaccuracies.
    • Understanding the interaction between immune cells and cancer cells is crucial for developing effective therapies.

    Purpose of the Study:

    • To investigate the control problem for cancer-tumor-immune systems using a two-dimensional uncertain nonlinear model.
    • To develop an adaptive control strategy to halt cancer growth and maintain cellular balance.
    • To address and overcome singularity and inaccuracy issues present in prior control designs.

    Main Methods:

    • The control problem was reformulated as a state tracking problem.
    • An adaptive control method was designed to manage cancer and immune cell populations.
    • Theoretical analysis was employed to prove the stability of the closed-loop system.
    • Simulation results were used to validate the control strategy.

    Main Results:

    • The proposed adaptive control method successfully tracks and stops cancer tumor growth.
    • Cancer and immune cell populations are maintained at acceptable levels.
    • The controller overcomes singularity problems and improves control design accuracy.
    • The closed-loop system demonstrates asymptotic stability with tracking errors converging to zero.
    • Simulations highlight the competitive dynamics between immune and tumor cells.

    Conclusions:

    • The developed adaptive control strategy is effective for managing cancer-tumor-immune systems.
    • The method provides a stable and accurate approach to cancer control, overcoming previous limitations.
    • The study confirms the immune system's capacity to combat low-volume tumors, offering insights into immunotherapy.